BIOASTER FONDATION DE COOPERATION SCIENT...
Desconocido
TRANSVAC-DS: DESIGN STUDY FOR A EUROPEAN VACCINE INFRASTRUCTURE
BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE
participó en un
H2020:
H2020-SC5-2018-2019-2020
The TRANSVAC-DS project further builds on the outstanding success of EC-funded projects:TRANSVAC1 and TRANSVAC2 and proposes the establishme...
2020-06-09 - 2023-02-28 | Financiado
2020-06-09 - 2023-02-28 | Financiado
INCENTIVE: Indo European Consortium for Next Generation Influenza Vaccine Innovation
BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE
participó en un
H2020:
H2020-SC1-BHC-2018-2020
The highly integrated INCENTIVE consortium represents true partnership between Indian and European/US groups that addresses the global healt...
2019-12-13 - 2025-07-31 | Financiado
2019-12-13 - 2025-07-31 | Financiado
ERA4TB: EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS
BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE
participó en un
H2020:
H2020-JTI-IMI2-2018-15-two-stage
The European Regimen Accelerator for Tuberculosis (ERA4TB) has the explicit goal of developing a new combination therapy to treat all forms...
2019-12-12 - 2025-12-31 | Financiado
2019-12-12 - 2025-12-31 | Financiado
GNA NOW: NOVEL GRAM NEGATIVE ANTIBIOTIC NOW
BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE
participó en un
H2020:
H2020-JTI-IMI2-2018-16-single-stage
AntiMicrobial Resistance (AMR) is a global and serious threat to human health. Gram-negative bacteria are widely regarded as the culprit rep...
2019-06-17 - 2025-12-31 | Financiado
2019-06-17 - 2025-12-31 | Financiado
VALUE-Dx: The value of diagnostics to combat antimicrobial resistance by optimising antibiotic use
Antimicrobial resistance (AMR) is of great public health concern, causing numerous losses of lives worldwide and threatening to reverse many...
2019-03-25 - 2024-09-30 | Financiado
2019-03-25 - 2024-09-30 | Financiado
FunHoMic: Deciphering the fungus host microbiota interplay to improve the management of fungal infections
BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE
participó en un
H2020:
H2020-MSCA-ITN-2018
Fungal infections have a major impact on human health, infecting about 2 billion people and killing more people each year than malaria or br...
2018-09-13 - 2023-06-30 | Financiado
2018-09-13 - 2023-06-30 | Financiado
TRANSVAC2: European Vaccine Research and Development Infrastructure
BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE
participó en un
H2020:
H2020-INFRAIA-2016-2017
TRANSVAC2 is the follow-up project to its successful predecessor project TRANSVAC, the European Network of Vaccine Research and Development...
2017-07-28 - 2023-04-30 | Financiado
2017-07-28 - 2023-04-30 | Financiado
NAREB: Nanotherapeutics for antibiotic resistant emerging bacterial pathogens
BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE
participó en un
FP7:
Increase in antibiotic resistance is a global concern worldwide. The project NAREB's main objective is the optimization of several nanoformu...
Financiado
Financiado
* No se disponen de datos de la empresa actual.